Medical diagnostics tech company Compumedics (ASX: CMP) has seen a surge in sales with its unaudited sales data showing $49 million in revenue for FY24 which would be a new record for the Company. Sales were driven by Compumedics’ Australian sleep and neurodiagnostic businesses which experienced significant growth, bolstered by two major Magnetoencephalography (MEG) orders
Read More
A semiconductor company with a quantum computing and medical diagnostics focus, Archer Materials Limited (ASX: AXE), has announced a notable development in its advanced Biochip graphene field effect transistor (gFET) technology. Archer has successfully demonstrated multiplexing readout capabilities for its Biochip, i.e. they have shown the device can make sense of multiple liquid samples arriving
Read More